WP2611: Characterization of nano-pharmaceuticals with field-flow fractionation and light scattering (FFF-MALS-DLS)

One of the primary challenges in developing effective formulations for the nanoscale delivery of therapeutics is particle characterization. The capabilities of FFF-MALS-DLS provide a pathway to meeting the requirements of regulatory agencies for enhanced characterization of liposomal drug formulations and other nanoparticle delivery systems and has led to the development of international standards literature for nanoparticle characterization such as ISO TS 21362 and ASTM WK 68060.